A $250m investment by Kuwait Investment Authority helped close the round, adding to funds provided by Celgene in June.

NantHealth, the healthcare subsidiary of US-based computing technology developer NantWorks, closed a $320m series B round last week after receiving a $250m investment from sovereign wealth fund Kuwait Investment Authority (KIA).

The funding came less than four months after NantHealth secured $25m from pharmaceutical company Celgene and roughly six months after KIA invested $100m, though it is unclear whether any of KIA’s previous funds contributed to the $320m figure.

NantHealth is developing a healthcare management system that will combine molecular…